Next Earnings date is expected on
08/10/2022
Landec (LNDC) reported late Wednesday a fiscal Q4 adjusted diluted loss of $0.01 per share, vs. breakeven in the year-ago quarter. Three analysts polled by...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Landec (LNDC) said late Thursday it closed the sale of its Curation Foods' assets related to BreatheWay packaging technology business for $3.2 million in...
Landec (LNDC) is facing macro headwinds including inflation and supply shortages that raise concerns over the company's ability to generate operating...
Celsius Holdings Inc. (CELH) delivered earnings and revenue surprises of 50% and 2.82%,...
| Address | 2811 Airpark Drive Santa Maria, California 93455 |
| Phone | +1.650.306.1650 |
| Number of Employees | 736 |
| Recent SEC Filing | 08/08/2022 4 |
| President, Chief Executive Officer & Director | Albert D. Bolles |
| Chief Financial Officer & Secretary | John D. Morberg |
| Vice President | James G. Hall |
| Price Open | $10.96 |
| Previous Close | $10.80 |
| 52 Week Range | $7.65 - 12.04 |
| Market Capitalization | $324.9 M |
| Shares Outstanding | 29.5 M |
| Sector | Health Technology |
| Industry | Pharmaceuticals: Major | Next Earnings Announcement | 08/10/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$1.05 |
| Beta vs. S&P 500 | N/A |
| Revenue | $557.6 M |
| Net Profit Margin | -12.83% |
| Return on Equity | -33.23% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
